Bioreactor cultivation enhances NTEB formation and differentiation of NTES cells into cardiomyocytes.

Autogenic embryonic stem cells established from somatic cell nuclear transfer (SCNT) embryos have been proposed as unlimited cell sources for cell transplantation-based treatment of many genetic and degenerative diseases, which can eliminate the immune rejection that occurs after transplantation. In the present study, pluripotent nuclear transfer ES (NTES) cell lines were successfully established from different strains of mice. One NTES cell line, NT1, with capacity of germline transmission, was used to investigate in vitro differentiation into cardiomyocytes. To optimize differentiation conditions for mass production of embryoid bodies (NTEBs) from NTES cells, a slow-turning lateral vessel (STLV) rotating bioreactor was used for culturing the NTES cells to produce NTEBs compared with a conventional static cultivation method. Our results demonstrated that the NTEBs formed in STLV bioreactor were more uniform in size, and no large necrotic centers with most of the cells in NTEBs were viable. Differentiation of the NTEBs formed in both the STLV bioreactor and static culture into cardiomyocytes was induced by ascorbic acid, and the results demonstrated that STLV-produced NTEBs differentiated into cardiomyocytes more efficiently. Taken together, our results suggested that STLV bioreactor provided a more ideal culture condition, which can facilitate the formation of better quality NTEBs and differentiation into cardiomyocytes more efficiently in vitro.

[1]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[2]  Maurizio Zuccotti,et al.  Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei , 1998, Nature.

[3]  L. Kuo,et al.  Differentiated cells are more efficient than adult stem cells for cloning by somatic cell nuclear transfer , 2006, Nature Genetics.

[4]  P. Lelkes,et al.  Neuroectodermal Cell Culture , 2002 .

[5]  Richard T. Lee,et al.  Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes , 2003, Circulation.

[6]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T G Hammond,et al.  Optimized suspension culture: the rotating-wall vessel. , 2001, American journal of physiology. Renal physiology.

[8]  David A. Wolf,et al.  Analysis of gravity-induced particle motion and fluid perfusion flow in the NASA-designed rotating zero-head-space tissue culture vessel , 1991 .

[9]  Hong Jiang,et al.  Creation of Engineered Cardiac Tissue In Vitro From Mouse Embryonic Stem Cells , 2006, Circulation.

[10]  David Tweedie,et al.  Differentiation of Pluripotent Embryonic Stem Cells Into Cardiomyocytes , 2002, Circulation research.

[11]  Peter W Zandstra,et al.  Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. , 2002, Biotechnology and bioengineering.

[12]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[13]  G. Daley,et al.  Correction of a Genetic Defect by Nuclear Transplantation and Combined Cell and Gene Therapy , 2002, Cell.

[14]  S. Nishikawa,et al.  Equivalency of Nuclear Transfer‐Derived Embryonic Stem Cells to Those Derived from Fertilized Mouse Blastocysts , 2006, Stem cells.

[15]  K. Boheler,et al.  Cardiomyocytes derived from embryonic stem cells. , 2005, Methods in molecular medicine.

[16]  P. Mombaerts,et al.  Odorant receptor gene choice is reset by nuclear transfer from mouse olfactory sensory neurons , 2004, Nature.

[17]  S. Orkin,et al.  Stem cells down under-ISSCR 2007. , 2007, Cell stem cell.

[18]  Y. Chisti,et al.  Hydrodynamic Damage to Animal Cells , 2001, Critical reviews in biotechnology.

[19]  Kevin Eggan,et al.  Mice cloned from olfactory sensory neurons , 2004, Nature.

[20]  P. Lelkes,et al.  Growing tissues in microgravity , 1998, Nature Medicine.

[21]  S. Hughes.  Cardiac stem cells , 2002, The Journal of pathology.

[22]  A. Trounson,et al.  Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei , 2000, Current Biology.

[23]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[24]  R. Jaenisch,et al.  ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[26]  W. Sanger,et al.  Producing primate embryonic stem cells by somatic cell nuclear transfer , 2007, Nature.

[27]  Hong Jiang,et al.  Enrichment of cardiomyocytes derived from mouse embryonic stem cells. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  V. Tabar,et al.  Differentiation of Embryonic Stem Cell Lines Generated from Adult Somatic Cells by Nuclear Transfer , 2001, Science.

[29]  D. Srivastava,et al.  Potential of stem-cell-based therapies for heart disease , 2006, Nature.

[30]  Robert Zweigerdt,et al.  Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. , 2005, Biotechnology and bioengineering.

[31]  M. West,et al.  Prospects for the use of nuclear transfer in human transplantation , 1999, Nature Biotechnology.

[32]  Smadar Cohen,et al.  Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation , 2004, Biotechnology and bioengineering.

[33]  R. Jaenisch,et al.  Monoclonal mice generated by nuclear transfer from mature B and T donor cells , 2002, Nature.

[34]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.